Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

FBXO11 Is a Candidate Tumor Suppressor in the Transformation of MDS to Secondary AML

Michael Schieber, MD, John D. Crispino, PhD MBA

Blood (2019) 134 (Supplement_1): 4217.

https://doi.org/10.1182/blood-2019-124007

Published: 2019

Journal Articles

Novel Mechanisms Underlying IMiDs Resistance in Multiple Myeloma: Therapeutic Implications

Jiye Liu, PhD, Wenrong Zhou, PhD, Lijie Xing, MD, Matthew Ho, Kenneth Wen, BS, Tianyu Song, Yu-Tzu Tai, PhD, Teru Hideshima, MD PhD, Yong Cang, PhD, Kenneth C Anderson, MD

Blood (2017) 130 (Supplement 1): 594.

https://doi.org/10.1182/blood.V130.Suppl_1.594.594

Published: 2017

Journal Articles

FBXO10 Targets HGAL for Degradation

Fengjie Guo, PhD, Xiaoyu Jiang, PhD, Domenico Roberti, Lixin Rui, PhD, Izidore S Lossos, MD

Blood (2015) 126 (23): 3904.

https://doi.org/10.1182/blood.V126.23.3904.3904

Published: 2015

Journal Articles

APC/C Cdh1 As a Mediator Of Hematopoietic Differentiation, Self-Renewal and Malignant Transformation

Andrea Schmidts, Daniel Ewerth, Dominik Schnerch, MD, Arunas Kvainickas, Dagmar Wider, Birgit Kügelgen, Heike L. Pahl, PhD, Monika Engelhardt, MD, Ralph Wäsch, MD

Blood (2013) 122 (21): 3676.

https://doi.org/10.1182/blood.V122.21.3676.3676

Published: 2013

Journal Articles

PD-1 Signals Inhibit Cell Cycle Progression by Mediating Upregulation of Both KIP and INK Family of Cdk Inhibitors

Julia Brown, Nikolaos Patsoukis, Vassiliki A Boussiotis, MD, PhD

Blood (2010) 116 (21): 585.

https://doi.org/10.1182/blood.V116.21.585.585

Published: 2010

Journal Articles

PML Protects HIPK2 and p300 from SCF-Mediated Ubiquitin-Dependent Degradation To Activate Transcription.

Yutaka Shima, PhD, Takito Shima, Tomoki Chiba, Ph.D., Tatsuro Irimura, Ph.D., Issay Kitabayashi, Ph.D.

Blood (2007) 110 (11): 2653.

https://doi.org/10.1182/blood.V110.11.2653.2653

Published: 2007

Journal Articles

Ubiquitin Ligase Component Fbw7 Regulates the Quiescence of Hematopoietic Stem Cells.

Sahoko Matsuoka, MD, PhD, Yuichi Oike, MD, PhD, Ichiro Onoyama, MD, PhD, Keiyo Takubo, MD, PhD, Keisuke Ito, MD, PhD, Fumio Arai, DDS, PhD, Yasuo Ikeda, MD, PhD, Keiko Nakayama, MD, PhD, Keiichi Nakayama, MD, PhD, Toshio Suda, MD, PhD

Blood (2006) 108 (11): 79.

https://doi.org/10.1182/blood.V108.11.79.79

Published: 2006

NARROW

FBXO11 Is a Candidate Tumor Suppressor in the Transformation of MDS to Secondary AML

Novel Mechanisms Underlying IMiDs Resistance in Multiple Myeloma: Therapeutic Implications

FBXO10 Targets HGAL for Degradation

APC/C Cdh1 As a Mediator Of Hematopoietic Differentiation, Self-Renewal and Malignant Transformation

PD-1 Signals Inhibit Cell Cycle Progression by Mediating Upregulation of Both KIP and INK Family of Cdk Inhibitors

PML Protects HIPK2 and p300 from SCF-Mediated Ubiquitin-Dependent Degradation To Activate Transcription.

Ubiquitin Ligase Component Fbw7 Regulates the Quiescence of Hematopoietic Stem Cells.

Email alerts

ASH Publications

American Society of Hematology

FBXO11 Is a Candidate Tumor Suppressor in the Transformation of MDS to Secondary AML

Novel Mechanisms Underlying IMiDs Resistance in Multiple Myeloma: Therapeutic Implications

FBXO10 Targets HGAL for Degradation

APC/C Cdh1 As a Mediator Of Hematopoietic Differentiation, Self-Renewal and Malignant Transformation

PD-1 Signals Inhibit Cell Cycle Progression by Mediating Upregulation of Both KIP and INK Family of Cdk Inhibitors

PML Protects HIPK2 and p300 from SCF-Mediated Ubiquitin-Dependent Degradation To Activate Transcription.

Ubiquitin Ligase Component Fbw7 Regulates the Quiescence of Hematopoietic Stem Cells.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only